Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB-Reference-Cited by-同舟云学术

Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB

Published:2023-01 Issue:1 Volume:23 Page:30-32
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Uraki Ryuta,Ito Mutsumi,Furusawa Yuri,Yamayoshi Seiya,Iwatsuki-Horimoto Kiyoko,Adachi Eisuke,Saito Makoto,Koga Michiko,Tsutsumi Takeya,Yamamoto Shinya,Otani Amato,Kiso Maki,Sakai-Tagawa Yuko,Ueki Hiroshi,Yotsuyanagi Hiroshi,Imai Masaki,Kawaoka Yoshihiro

Funder

National Institute of Allergy and Infectious Diseases

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference3 articles.

1. Insights on the mutational landscape of the SARS-CoV-2 omicron variant receptor-binding domain;Miller;Cell Rep Med,2022

2. Imai M, Ito M, Kiso M, et al. Efficacy of antiviral agents against omicron BQ.1.1 and XBB subvariants. N Engl J Med (in press).

3. Imprinted SARS-CoV-2 humoral immunity induces convergent omicron RBD evolution;Cao;bioRxiv,2022

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers;Vaccine;2024-12

2. Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters;Molecular Therapy - Methods & Clinical Development;2024-09

3. Drug susceptibility and the potential for drug-resistant SARS-CoV-2 emergence in immunocompromised animals;iScience;2024-09

4. Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants;iScience;2024-09

5. Beyond COVID-19: the promise of next-generation coronavirus vaccines;npj Viruses;2024-08-22